Sihuan Pharmaceutical Holdings Group Ltd is engaged in the healthcare sector. The company conducts the business of developing pharmaceutical products. Its portfolio comprises of include Kelinao, Anjieli and Oudimei which are suitable for curing diseases related to the cardio-cerebral vascular (CCV) system, central nervous system, metabolism and oncology. The scope of its activities includes research and development, manufacture and sales of pharmaceutical products in China.
Beijing, 10025, Bermuda